Coagulation/Hemostasis Analyzer Market - Forecast(2021 - 2026)

Report Code: HCR 0517 Report Format: PDF + Excel (Delivery in 48 Hrs)

Coagulation/Hemostasis Analyzer Market Report Overview

Coagulation/Hemostasis Analyzer Market size in 2019 is estimated to be $3.3 billion, growing at a CAGR of 9.8% during the forecast period 2020-2025. Coagulation/Hemostasis Analyzer provide measurement of Blood platelet levels in a quick and simple process. It is a device that measure speed of coagulation pathway and thrombolin and thromboplastin levels in less time. It helps to provide diagnostic prevention from heart attack including blood clot also it is used to detect clotting deficiencies related diseases such as hemophilia von Willebrand disease and other conditions. Increasing prevalence of Cardiovascular diseases and blood disorders coupled with rising geriatric population are the major factors driving the growth of the market. Moreover, growing laboratory automation further enhance the overall market demand for Coagulation/Hemostasis Analyzer during the forecast period 2020-2025.

Report Coverage

The report: “Coagulation/Hemostasis Analyzer Market – Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Coagulation/Hemostasis Analyzer Market:
By Product Type : Clinical Laboratory Analyzers, Point-Of-Care Testing Analyzers, Consumables, Automated Analyzers.
By Test : APTT Tests, D Dimer Tests, Fibrinogen Tests, Prothrombin Time Tests.
By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology, Others.
By End User : Clinical Laboratories, Point-Of-Care Testing, Research and Development Organisations, Others.
By Geography : North America, Europe, Asia-Pacific, and Rest of the World.

Key Takeaways

  • In 2019, North America dominates the Coagulation/Hemostasis Analyzer Market owing to increasing prevalence of blood disorders conditions.
  • Increasing geriatric population coupled with rising prevalence of cardiovascular diseases are driving the market growth of Coagulation/Hemostasis Analyzer. 
  • Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Coagulation/Hemostasis Analyzer Market report.
  • High cost of automated Coagulation analyzers and slow acceptance of advance hemostasis instrument in emerging economies are challenging the growth of the market. 

Coagulation/Hemostasis Analyzer Market Segment Analysis - By Product Type

Based on the Product Type, Coagulation/Hemostasis Analyzer Market is segmented into Clinical Laboratory Analyzers, Point-Of-Care Testing Analyzers, Consumables, Automated Analyzers. The Clinical Laboratory Analyzers segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 7.6% during the forecast period 2020-2025. This is mainly owing to it mostly being used in hospitals for hematological analysis of patients. Moreover, it is fast and quick for testing, contributing to the growth of this segment.

Coagulation/Hemostasis Analyzer Market Segment Analysis - By Test

Based on the Test, Coagulation/Hemostasis Analyzer Market is segmented into APTT Tests, D dimer Tests, Fibrinogen Tests, Prothrombin Time Tests. In 2019, Prothrombin Time Tests held the largest share in the Coagulation/Hemostasis Analyzers market. This is mainly owing to high usage of Prothrombin Time Tests as it measures the time it takes for blood plasma to clot. Moreover, Prothrombin Time Tests helps to detect bleeding problems is also contributing to the growth of this segment.

Coagulation/Hemostasis Analyzer Market Segment Analysis - By End User

Based on the end user, Coagulation/Hemostasis Analyzer Market is segmented into Clinical Laboratories, Point-Of-Care Testing, Research and Development Organisations, Others. In 2019, Clinical Laboratories held the largest share in the Coagulation/Hemostasis Analyzers market. This is mainly owing to large volume of coagulation testing being performed at clinical laboratories. Moreover, government support towards setup and testing is also contributing to the growth of this segment

Coagulation/Hemostasis Analyzer Market Segment Analysis - Geography 

North America dominated the Coagulation/Hemostasis Analyzer market share accounting for 43% of the market in 2019. This is mainly owing to increasing prevalence blood disorders in this region. According to American Society of Hematology, Anemia is most common blood disorder in America and around 3 million Americans affects anemia.  Lack of iron among these patients increase the risk of clots. 

However, the Asia-Pacific region is projected to be the fastest-growing during the forecast period 2020-2025. This is owing to increasing awareness among people about blood disorder conditions coupled with rising geriatric population.

Coagulation/Hemostasis Analyzer Market Drivers 

Increasing prevalence of Diseases

Increasing prevalence of blood disorder conditions as well as various cardiovascular diseases among the population globally are driving the growth of Coagulation/Hemostasis Analyzer market. According to, World Federation of Hemophilia, in 2018, 337,000 people living with bleeding disorders in the world. According to World Health Organization (WHO), cardiovascular diseases are the leading cause of death in globally, and cause around 17.9 million deaths annually in worldwide.

Growing Technology Advancement

Growing technological advancement such as laboratory automation are some factors driving the growth of the market. Moreover, development of high-sensitivity point of care (POC) coagulation testing further contributing to the growth of Coagulation/Hemostasis Analyzer Market.

Coagulation/Hemostasis Analyzer Market Challenges

High cost of fully automated coagulation analyzer coupled with slow acceptance of advance hemostasis instrument in emerging economies are challenging the growth of the market. Moreover, strict regulatory policies for medical equipment are further restraining its market growth in certain regions during the forecast period 2020-2025.

Coagulation/Hemostasis Analyzer Industry Outlook

Product launches, Merger & Acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Coagulation/Hemostasis Analyzer Market. Coagulation/Hemostasis Analyzer top 10 companies are Abbott Laboratories, Siemens Healthineers Group, Thermo Fisher Scientific, Biosystems S.A., Sysmex Corporation, A&T Corporation, Roche Diagnostics, International Technidyne Corporation (ITC), Nihon Kohden Corporation, Alere Inc.

Acquisitions/Product Launches:

  • In December 2018, Sysmex Corporation, a leading company in blood coagulation analyzers has launched Automated Blood Coagulation Analyzers CN-6000 and CN-3000. 
  • In May 2018, Beckman Coulter has launched DxH 900 hematology analyzer and it is available in Europe, U.S., Australia and New Zealand.

1. Coagulation/Hemostasis Analyzer Market Overview
    1.1 Definitions and Scope
2. Coagulation/Hemostasis Analyzer Market - Executive Summary
    2.1 Market Size and Key Trends
    2.2 Key trends by Product Type
    2.3 Key trends by Test
    2.4 Key trends by Technology
    2.5 Key trends by End User
    2.6 Key trends by Geography
3. Coagulation/Hemostasis Analyzer Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Coagulation/Hemostasis Analyzer Market - Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Coagulation/Hemostasis Analyzer Market - Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Coagulation/Hemostasis Analyzer Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes 
7. Coagulation/Hemostasis Analyzer Market - Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Coagulation/Hemostasis Analyzer Market – By Product Type (Market Size - $Million/$Billion)
    8.1 Clinical Laboratory Analyzers
    8.2 Point-Of-Care Testing Analyzers
    8.3 Consumables
    8.4 Automated Analyzers
9. Coagulation/Hemostasis Analyzer Market - By Test (Market Size - $Million/$Billion)
    9.1 APTT Tests
    9.2 D Dimer Tests
    9.3 Fibrinogen Tests
    9.4 Prothrombin Time Tests
10. Coagulation/Hemostasis Analyzer Market – By Technology (Market Size - $Million/$Billion)
    10.1 Optical Technology
    10.2 Mechanical Technology
    10.3 Electrochemical Technology
    10.4 Others
11. Coagulation/Hemostasis Analyzer Market – By End User (Market Size - $Million/$Billion)
    11.1 Clinical Laboratories
    11.2 Point-Of-Care Testing
    11.3 Research and Development Organisations
    11.4 Others
12. Coagulation/Hemostasis Analyzer Market - By Geography (Market Size - $Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 Japan
        12.3.3 South Korea
        12.3.4 India
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia-Pacific
    12.4 Rest of the World
        12.4.1 Middle East
        12.4.2 Africa
        12.4.3 South America
13. Coagulation/Hemostasis Analyzer Market – Entropy
14. Coagulation/Hemostasis Analyzer Market - Industry / Segment Competition landscape Premium Premium
    14.1 Market Share Analysis
        14.1.1 Market Share by Country - Key companies
        14.1.2 Market Share by Region - Key companies
        14.1.3 Market Share at Global Level- Key companies
        14.1.4 Best Practices for Companies
15. Coagulation/Hemostasis Analyzer Market- Key Company List by Country Premium Premium
16. Coagulation/Hemostasis Analyzer Market Company Analysis
    16.1 Company Revenue, Products, M&A, Developments
    16.2 Company 1
    16.3 Company 2
    16.4 Company 3
    16.5 Company 4
    16.6 Company 5
    16.7 Company 6
    16.8 Company 7
    16.9 Company 8
    16.10 Company 9
    16.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.